 |
 |
|
|
RESÚMENES OCTUBRE 2004 |
Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers
(Requiere estar conectado a internet. Haga un click en la
información del journal)
The effect of
escitalopram, desipramine, electroconvulsive seizures and lithium on
brain-derived neurotrophic factor mRNA and protein expression in the rat brain
and the correlation to 5-HT and 5-HIAA levels
Ramsøe Jacobsen and
Arne Mørk
Burden of general medical conditions among individuals with bipolar
disorder.
Kilbourne
AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, Conigliaro J, Haas GL.
Bipolar Disord 2004: 6:
368-373
Quality of life in patients with bipolar I depression: data from 920
patients.
Yatham
LN, Lecrubier Y, Fieve RR, Davis KH, Harris SD, Krishnan AA.
Bipolar Disord 2004: 6:
379-385
Bipolar disorder in older adults: a critical review.
Depp
CA, Jeste DV.
Bipolar Disord 2004: 6:
343-367
A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
Jairam
R, Srinath S, Girimaji SC, Seshadri SP.
Bipolar Disord 2004: 6:
386-394
The clinical characteristics of DSM-IV bipolar I and II disorders:
baseline findings from the Jorvi Bipolar Study (JoBS).
Mantere
O, Suominen K, Leppämäki S, Valtonen H, Arvilommi P, Isometsä E.
Bipolar Disord 2004: 6:
395-405
Medication use patterns and 2-year outcome in first-admission bipolar
disorder with psychotic features.
Craig
TJ, Grossman S, Mojtabai R, Gibson PJ, Lavelle J, Carlson GA, Bromet EJ.
Bipolar Disord 2004: 6:
406-415
Gender differences in the phenomenology of bipolar disorder.
Kessing
LV.
Bipolar Disord 2004: 6:
421-425
Peripheral thyroid hormones
and response to selective serotonin reuptake inhibitors
Michael Gitlin, Lori L.
Altshuler, Mark A. Frye, Rita Suri, Emily L. Huynh,
Lynn Fairbanks, Michael Bauer, Stanley Korenman
J Psychiatry Neurosci 2004;29(5):383-6
An
open trial of venlafaxine for the treatment of late-life atypical depression.
Roose SP, Miyazaki M,
Devanand D, Seidman S, Fitzsimmons L, Turret N, Sackeim H
Int J Geriatr Psychiatry. 2004 Sep 27;19(10):989.
[Epub ahead of print]
Tuula Kieseppä, Timo Partonen, Jari Haukka, Jaakko Kaprio, and Jouko
Lönnqvist
Am J Psychiatry 161:1814-1821, October 2004
Randomized, Placebo-Controlled Trial of Fluoxetine for Acute Treatment of Minor Depressive Disorder
Lewis L. Judd, Mark Hyman Rapaport, Kimberly A. Yonkers, A. John Rush,
Ellen Frank, Michael E. Thase, David J. Kupfer, John M. Plewes, Pamela J.
Schettler, and Gary Tollefson
Am J Psychiatry 161:1864-1871, October 2004
Relationship of Variability in Residual Symptoms With Recurrence of Major Depressive Disorder During Maintenance Treatment
Jordan F. Karp, Daniel J. Buysse, Patricia R. Houck, Christine Cherry,
David J. Kupfer, and Ellen Frank
Am J Psychiatry 161:1877-1884, October 2004
Philip S. Wang, Arne L. Beck, Pat Berglund, David K. McKenas, Nicolaas
P. Pronk, Gregory E. Simon, and Ronald C. Kessler
Am J Psychiatry 161:1885-1891, October 2004
Phenomenology of Rapid-Cycling Bipolar Disorder: Data From the First 500 Participants in the Systematic Treatment Enhancement Program
Christopher D. Schneck, David J. Miklowitz, Joseph R. Calabrese,
Michael H. Allen, Marshall R. Thomas, Stephen R. Wisniewski, Sachiko Miyahara,
Melvin D. Shelton, Terence A. Ketter, Joseph F. Goldberg, Charles L. Bowden,
and Gary S. Sachs
Am J Psychiatry
161:1902-1908, October 2004
Vulnerability Before, During, and After a Major Depressive
Episode. A 3-Wave Population-Based Study
Johan
Ormel, Albertine J. Oldehinkel, Wilma Vollebergh
Arch Gen Psychiatry. 2004;61:990-996.
Fluoxetine,
Comprehensive Cognitive Behavioral Therapy, and Placebo in Generalized Social
Phobia
Jonathan
R. T. Davidson, Edna B. Foa, Jonathan D. Huppert, Francis J. Keefe, Martin E.
Franklin, Jill S. Compton, Ning Zhao, Kathryn M. Connor, Thomas R. Lynch,
Kishore M. Gadde
Arch Gen Psychiatry. 2004;61:1005-1013
Carrie L. Ernst and
Joseph F. Goldberg
Jan Neeleman, Ron
de Graaf and Wilma Vollebergh
Age effects on
cortisol levels in depressed patients with and without comorbid post-traumatic
stress disorder, and healthy volunteers
Leo Sher, Maria A.
Oquendo, Hanga C. Galfalvy, Thomas B. Cooper and J. J. Mann
Use of
prescription medications and complementary and alternative medicines to treat
depressive and anxiety symptoms: results from a community sample
Ruth A. Parslow and
Anthony F. Jorm
Comorbid major
depression and panic disorder: significance of temporal sequencing to familial
transmission
Lilian Dindo and
William Coryell
Christer Engström,
Sven Brändström, Sören Sigvardsson, Robert Cloninger and Per-Olof Nylander
Gianni L. Faedda,
Ross J. Baldessarini, Ira P. Glovinsky and Nancy B. Austin
Paroxetine
controlled release for premenstrual dysphoric disorder: a double-blind,
placebo-controlled trial.
Cohen LS, Soares CN,
Yonkers KA, Bellew KM, Bridges IM, Steiner M.
Psychosom Med. 2004 Sep-Oct;66(5):707-13
Depression and
lipoprotein lipids in healthy, postmenopausal women. The moderating effects of
hormone replacement therapy
Raymonde A. Brown,
Paul P. Giggey, Karen E. Dennisc and Shari R. Waldstein
Journal of Psychosomatic Research. Volume 57, Issue 2,
August 2004, Pages 171-176
MRI of the
brainstem in patients with major depression, bipolar affective disorder and
normal controls
Tillmann Supprian,
Werner Reiche, Bernd Schmitz, Iris Grunwald, Martin Backens, Erich Hofmann,
Thomas Georg, Peter Falkai and Wolfgang Reith
Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression
Boris B. Quednow,
Kai-Uwe Kühn, Richard Stelzenmueller, Klaus Hoenig,
Wolfgang Maier and Michael Wagner
Psychopharmacology 2004; Volume 175, Number
4: 399 - 406
Olanzapine
versus fluphenazine in an open trial in patients with psychotic combat-related
post-traumatic stress disorder
Nela Pivac,
Dragica Kozaric-Kovacic and Dorotea Muck-Seler
Psychopharmacology 2004; Volume 175, Number
4: 451 - 456
A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients
Walter W. van
den Broek, Tom K. Birkenhäger, Paul G. H. Mulder,
Jan A. Bruijn and Peter Moleman
Psychopharmacology 2004; Volume 175, Number
4: 481 - 486
Population
pharmacokinetic analysis of mirtazapine
Katja Grasmäder,
Petra Louise Verwohlt, Kai-Uwe Kühn, Aleksandra Dragicevic,
Olrik von Widdern, Astrid Zobel, Christoph Hiemke,
Marcella Rietschel, Wolfgang Maier, Ulrich Jaehde and
Marie Luise Rao
European Journal of Clinical Pharmacology 2004; Volume
60, Number 7: 473 - 480
Review and Update
of the American Psychiatric Association Practice Guideline for Bipolar Disorder
James
C-Y.Chou
Primar y Psychiatry.2004;11(9):73-84
Javaid
I.Sheikh
Primar y Psychiatry.2004;11(8):51-54
Improvement
of positive and negative syndrome scale cognitive score associated with
olanzapine treatment of acute mania.
Shi L, Schuh LM, Trzepacz
PT, Huang LX, Namjoshi MA, Tohen M
Curr Med Res Opin. 2004 Sep;20(9):1371-6
Role of presynaptic alpha2-adrenoceptors in antidepressant action: Recent findings from microdialysis studies.
Invernizzi RW,
Garattini S.
Prog Neuropsychopharmacol Biol Psychiatry
2004;28(5):819-827
The
efficacy of duloxetine: A comprehensive summary of results from MMRM and
LOCF_ANCOVA in eight clinical trials
Craig
H Mallinckrodt, Joel Raskin, Madelaine M Wohlreich, John G Watkin and Michael J
Detke
BMC Psychiatry 2004, 4:26
The
link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with
anxiety and mood disorders in the community: a field of interest for public
health in the future
Mauro
Giovanni Carta, Andrea Loviselli, Maria Carolina Hardoy, Sergio Massa,
Mariangela Cadeddu, Claudia Sardu, Bernardo Carpiniello, Liliana Dell'Osso and
Stefano Mariotti
BMC Psychiatry 2004, 4:25
Three
year naturalistic outcome study of panic disorder patients treated with
paroxetine
Pinhas
N Dannon, Iulian Iancu, Ami Cohen, Katherine Lowengrub, Leon Grunhaus and Moshe
Kotler
BMC Psychiatry 2004, 4:16
Suicide
and no axis I psychopathology
Carl
Ernst, Aleksandra Lalovic, Alain Lesage, Monique Seguin, Michel Tousignant and
Gustavo Turecki
Thyroid
function in clinical subtypes of major depression: an exploratory study
Konstantinos
N Fountoulakis, Apostolos Iacovides, Philippos Grammaticos, George St Kaprinis
and Per Bech
BMC Psychiatry 2004, 4:6
The relationship
between pain and negative affect in older adults: anxiety as a predictor of
pain
Sharon L. Feeney
Ming Tsuang,
Katharina Domschke, Beth A. Jerskey and Michael J. Lyons
Late-life anxiety
disorders among Puerto Rican primary care patients: impact on well-being,
functioning, and service utilization
Gretchen J.
Diefenbach, Julie T. Robison, David F. Tolin and Karen Blank
Selective
serotonin reuptake inhibitor and venlafaxine use in children and adolescents
with major depressive disorder: a systematic review of published randomized
controlled trials.
Courtney DB.
Can J Psychiatry. 2004 Aug;49(8):557-63
Chronic olanzapine
or fluoxetine administration increases cell proliferation in hippocampus and
prefrontal cortex of adult rat
Masafumi Kodama,
Takashi Fujioka and Ronald S. Duman
Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study
L. S. Cohen,
R. M. Nonacs, J. W. Bailey, A. C. Viguera, A. M. Reminick,
L. L. Altshuler, Z. N. Stowe and S. V. Faraone
Archives of Women's Mental Health 2004; Volume 7,
Number 4: 217 - 221
Hypericum
extract in patients with MDD and reversed vegetative signs: re-analysis from
data of a double-blind, randomized trial of hypericum extract, fluoxetine, and
placebo.
Murck H, Fava M, Alpert J,
Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Mannel M, Rosenbaum JF.
Int J Neuropsychopharmacol. 2004 Sep 30:1-7 [Epub
ahead of print]
Early- versus
late-onset obsessive–compulsive disorder: investigating genetic and clinical
correlates
Sîan M. J.
Hemmings, Craig J. Kinnear, Christine Lochner, Dana J. H. Niehaus, James A.
Knowles, Johanna C. Moolman-Smook, Valerie A. Corfield and Dan J. Stein
Psychiatry
Research. Volume 128, Issue 2, 30 September 2004, Pages 175-182
Efficacy of
open-label venlafaxine in subjects with major depressive disorder: associations
with neuroendocrine response to serotonergic and noradrenergic probes
Robert Grossman,
Dierdre Reynolds, Maryanne Goodman, Antonia New, Jeremy Silverman, James
Schmeidler, Vivian Mitropoulou and Larry J. Siever
Remission rates with venlafaxine extended release in Greek outpatients
with generalized anxiety disorder. A double-blind, randomized, placebo controlled
study.
Nimatoudis, I; Zissis, N. P; Kogeorgos, J;
Theodoropoulou, S; Vidalis, A; Kaprinis, G
International Clinical Psychopharmacology.
19(6):331-336, November 2004.
Controlled comparison of two different doses of milnacipran in major
depressive outpatients.
Kanemoto, Kousuke; Matsubara, Momoyo;
Yamashita, Koichi; Tarao, Yoko; Inada, Eriko; Sekine, Tatsuo
International Clinical Psychopharmacology.
19(6):343-346, November 2004.
Temporal relation between depression and cognitive impairment in old age: prospective population based study
David J Vinkers,
Jacobijn Gussekloo, Max L Stek, Rudi G J Westendorp, Roos C van der Mast
Chronic
antidepressant medication attenuates dexamethasone-induced neuronal death and
sublethal neuronal damage in the hippocampus and striatum
Linda E. Haynes,
Dave Barber and Ian J. Mitchell
Extended-release
divalproex sodium for mood stabilization.
Stoner SC, Dubisar BM, Lea
JW, Marken PA, Ramlatchman LV, Reynolds JB
Pharmacotherapy. 2004 Sep;24(9):1147-53
A 3-Month Follow-Up Randomized Placebo-Controlled Study of
Repetitive Transcranial Magnetic Stimulation in Depression
Frank Koerselman,
D. Martin Laman;Hans van Duijn; Marijtje A. J. van Duijn; and Martin A. M.
Willems
J Clin Psychiatry 2004;65:1323-1328
Effectiveness of Low Doses of Paroxetine Controlled
Release in the Treatment of Major Depressive Disorder
Madhukar H.
Trivedi, Teresa A. Pigott, Philip Perera, Kerry E. Dillingham, Michelle L.
Carfagno, and Cornelius D. Pitts
J Clin Psychiatry 2004;65:1356-1364
Weight Gain During Long-Term Treatment ofObsessive-Compulsive
Disorder: A Prospective Comparison Between Serotonin Reuptake Inhibitors
Giuseppe Maina,
Umberto Albert, Virginio Salvi, and Filippo Bogetto
J Clin Psychiatry 2004;65:1365-1371
Attitudes of Schizophrenia Outpatients Toward Psychiatric
Medications: Relationship to Clinical Variables and Insight
Oliver
Freudenreich, Corinne Cather, A. Eden Evins, David C. Henderson, and Donald C.
Goff
J Clin Psychiatry 2004;65:1372-1376
Response Acceleration With Mirtazapine Augmentation of
Citalopram in Obsessive-Compulsive Disorder Patients Without Comorbid
Depression: A Pilot Study
Stefano Pallanti,
Leonardo Quercioli, and Matteo Bruscoli
J Clin Psychiatry 2004;65:1394-1399
Comparison of Rapid-Cycling and Non-Rapid-Cycling Bipolar
I Manic Patients During Treatment With Olanzapine:Analysis of Pooled Data
Eduard Vieta,
Joseph R. Calabrese, John Hennen, Francesc Colom, Anabel Martínez-Arán, Jose
Sánchez-Moreno, Lakshmi N. Yatham, Mauricio Tohen, and Ross J. Baldessarini
J Clin Psychiatry 2004;65:1420-1428
Single
photon emission computed tomography (SPECT) of anxiety disorders before and
after treatment with citalopram
Paul
D Carey, James Warwick, Dana JH Niehaus, Geoffrey van der Linden, Barend B van
Heerden, Brian H Harvey, Soraya Seedat and Dan J Stein
BMC Psychiatry 2004, 4:30; 14 October 2004
Do antipsychotics
ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic
review
Jitender Sareen,
Alla Kirshner, Mark Lander, Kevin D. Kjernisted, Michael K. Eleff and Jeffrey
P. Reiss
Journal
of Affective Disorders. Volume 82, Issue 2, 15 October 2004, Pages 167-174
Decreased activation of the anterior
cingulate in bipolar patients: an fMRI study
Staci A. Gruber,
Jadwiga Rogowska and Deborah A. Yurgelun-Todd
Is the type of
remission after a major depressive episode an important risk factor to relapses
in a 4-year follow up?
Luis Pintor, Xavier
Torres, Victor Navarro, Silvia Matrai and Cristobal Gastó
Journal
of Affective Disorders. Volume 82, Issue 2, 15 October 2004, Pages 291-296
Safety of
Hypericum extract in mildly to moderately depressed outpatients. A review based
on data from three randomized, placebo-controlled trials
R. D.
Trautmann-Sponsel and Angelika Dienel
PET
brain imaging with [11C](+)McN5652 shows increased serotonin
transporter availability in major depression
Martin Reivich, Jay
D. Amsterdam, David J. Brunswick and Chyng Yann Shiue
Effects
of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine
Kazushi Sawamura,
Yutaro Suzuki and Toshiyuki Someya
European Journal of Clinical Pharmacology 2004; Volume
60, Number 8: 553 - 557
Synergistic
dopamine increase in the rat prefrontal cortex with the combination of
quetiapine and fluvoxamine
Damiaan Denys,
André A. Klompmakers and Herman G. M. Westenberg
Psychopharmacology 2004;Volume 176, Number 2: 195
- 203
Clinical
correlates and symptom patterns of anxious depression among patients with major
depressive disorder in STAR*D
MAURIZIO FAVA,
JONATHAN E. ALPERT, CHERYL N. CARMIN, STEPHEN R. WISNIEWSKI,
MADHUKAR H. TRIVEDI, MELANIE M. BIGGS, KATHY SHORES-WILSON,
DON MORGAN, TERRY SCHWARTZ, G. K. BALASUBRAMANI and A. JOHN
RUSH
Psychological Medicine (2004), 34:7:1299-1308
Genetic and
environmental influences on the association between smoking and panic attacks
in females: a population-based twin study
TED REICHBORN-KJENNERUD,
ESPEN RØYSAMB, KRISTIAN TAMBS, SVENN TORGERSEN,
EINAR KRINGLEN, PER MAGNUS and JENNIFER R. HARRIS
Psychological Medicine (2004), 34:7:1271-1277
Wolfgang Hiller, Rolf Leibbrand and Manfred M. Fichter
Partial
PTSD versus full PTSD: an
empirical examination of associated impairment
NAOMI BRESLAU,
VICTORIA C. LUCIA and GLENN C. DAVIS
Psychological Medicine (2004), 34:7:1205-1214
Uriel Nitzan,
medical student, Pesach Lichtenberg
BMJ 2004;329:944-946 (23 October,
2004)
Drug-induced lithium toxicity in the elderly: a population-based study.
Juurlink DN,
Mamdani MM, Kopp A, et al.
Clinical
efficacy of citalopram in patients with hypertension and concomitant depression
Pogosova GV, Gudkova OA, Iufereva IuM, Tikhomirova EA
Kardiologiia. 2004;44(10):49-53
Farhat Rasul,
Stephen A. Stansfeld, Carole L. Hart, Charles R. Gillis and George Davey Smith
The Munich
vulnerability study on affective disorders: premorbid neuroendocrine profile of
affected high-risk probands
M. Ising, C. J.
Lauer, F. Holsboer and S. Modell
Duloxetine
60 mg once-daily in the treatment of painful physical symptoms in patients with
major depressive disorder
Stephen K. Brannan,
Craig H. Mallinckrodt, Eileen B. Brown, Madelaine M. Wohlreich, John G. Watkin
and Alan F. Schatzberg
Natalie Rasgon,
Michael Bauer, Paul Grof, Laszlo Gyulai, Shana Elman, Tasha Glenn and Peter C.
Whybrow
Cognitive-Behavior Therapy, Sertraline, and Their Combination
for Children and Adolescents With Obsessive-Compulsive Disorder. The Pediatric OCD
Treatment Study (POTS) Randomized Controlled Trial
The
Pediatric OCD Treatment Study (POTS) Team
Pharmacokinetics/Pharmacodynamics
of desloratadine and fluoxetine in healthy volunteers.
Gupta S, Banfield C,
Kantesaria B, Flannery B, Herron J
J Clin Pharmacol. 2004 Nov;44(11):1252-9
Depression
in primary care: effectiveness of venlafaxine extended-release in elderly
patients; Observational study.
Cervera-Enguix S,
Baca-Baldomero E, Garcia-Calvo C, Prieto-Lopez R; TESEO Study Group